These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 33000323)
1. Unusual case of biotin-thiamine responsive encephalopathy without basal ganglia involvement. Kelsch RD; Nolan DA; Krishnan A Pediatr Radiol; 2021 Mar; 51(3):485-488. PubMed ID: 33000323 [TBL] [Abstract][Full Text] [Related]
2. Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases. Alfadhel M; Almuntashri M; Jadah RH; Bashiri FA; Al Rifai MT; Al Shalaan H; Al Balwi M; Al Rumayan A; Eyaid W; Al-Twaijri W Orphanet J Rare Dis; 2013 Jun; 8():83. PubMed ID: 23742248 [TBL] [Abstract][Full Text] [Related]
3. Biotin-thiamine-responsive basal ganglia disease: catastrophic consequences of delay in diagnosis and treatment. Algahtani H; Ghamdi S; Shirah B; Alharbi B; Algahtani R; Bazaid A Neurol Res; 2017 Feb; 39(2):117-125. PubMed ID: 27905264 [TBL] [Abstract][Full Text] [Related]
4. Neonatal form of biotin-thiamine-responsive basal ganglia disease. Clues to diagnosis. Değerliyurt A; Gündüz M; Ceylaner S; Ünal Ö; Ünal S Turk J Pediatr; 2019; 61(2):261-266. PubMed ID: 31951338 [TBL] [Abstract][Full Text] [Related]
5. Beyond the caudate nucleus: Early atypical neuroimaging findings in biotin-thiamine- responsive basal ganglia disease. Alsini H; Alnozha A; Asmat Z; Hundallah K; Alfadhel M; Tabarki B Brain Dev; 2022 Oct; 44(9):618-622. PubMed ID: 35811190 [TBL] [Abstract][Full Text] [Related]
6. Biotin-Responsive Basal Ganglia Disease: Treatable Metabolic Disorder with SLC19A3 Mutation Presenting as Rapidly Progressive Dementia. Oommen AT; Polavarapu K; Christopher R; Netravathi M Neurol India; 2022; 70(2):733-736. PubMed ID: 35532649 [TBL] [Abstract][Full Text] [Related]
7. Are diagnostic magnetic resonance patterns life-saving in children with biotin-thiamine-responsive basal ganglia disease? Kamaşak T; Havalı C; İnce H; Eyüboğlu İ; Çebi AH; Sahin S; Cansu A; Aydin K Eur J Paediatr Neurol; 2018 Nov; 22(6):1139-1149. PubMed ID: 30054086 [TBL] [Abstract][Full Text] [Related]
8. Biotin and Thiamine Responsive Basal Ganglia Disease--A vital differential diagnosis in infants with severe encephalopathy. Ygberg S; Naess K; Eriksson M; Stranneheim H; Lesko N; Barbaro M; Wibom R; Wang C; Wedell A; Wickström R Eur J Paediatr Neurol; 2016 May; 20(3):457-61. PubMed ID: 26975589 [TBL] [Abstract][Full Text] [Related]
9. Biotin-thiamine responsive basal ganglia disease in the era of COVID-19 outbreak diagnosis not to be missed: A case report. Al-Anezi A; Sotirova-Koulli V; Shalaby O; Ibrahim A; Abdulmotagalli N; Youssef R; Hossam El-Din M Brain Dev; 2022 Apr; 44(4):303-307. PubMed ID: 34953623 [TBL] [Abstract][Full Text] [Related]
14. Biotin-thiamine responsive basal ganglia disease: Identification of a pyruvate peak on brain spectroscopy, novel mutation in SLC19A3, and calculation of prevalence based on allele frequencies from aggregated next-generation sequencing data. Ferreira CR; Whitehead MT; Leon E Am J Med Genet A; 2017 Jun; 173(6):1502-1513. PubMed ID: 28402605 [TBL] [Abstract][Full Text] [Related]
15. Biotin-responsive basal ganglia disease: neuroimaging features before and after treatment. Kassem H; Wafaie A; Alsuhibani S; Farid T AJNR Am J Neuroradiol; 2014 Oct; 35(10):1990-5. PubMed ID: 24812013 [TBL] [Abstract][Full Text] [Related]
16. Compound heterozygous Whitford W; Hawkins I; Glamuzina E; Wilson F; Marshall A; Ashton F; Love DR; Taylor J; Hill R; Lehnert K; Snell RG; Jacobsen JC Cold Spring Harb Mol Case Stud; 2017 Nov; 3(6):. PubMed ID: 28696212 [TBL] [Abstract][Full Text] [Related]
17. A case report of biotin-thiamine-responsive basal ganglia disease in a Saudi child: Is extended genetic family study recommended? Aljabri MF; Kamal NM; Arif M; AlQaedi AM; Santali EYM Medicine (Baltimore); 2016 Oct; 95(40):e4819. PubMed ID: 27749535 [TBL] [Abstract][Full Text] [Related]
18. Novel SLC19A3 Promoter Deletion and Allelic Silencing in Biotin-Thiamine-Responsive Basal Ganglia Encephalopathy. Flønes I; Sztromwasser P; Haugarvoll K; Dölle C; Lykouri M; Schwarzlmüller T; Jonassen I; Miletic H; Johansson S; Knappskog PM; Bindoff LA; Tzoulis C PLoS One; 2016; 11(2):e0149055. PubMed ID: 26863430 [TBL] [Abstract][Full Text] [Related]
19. Stress-induced upregulation of SLC19A3 is impaired in biotin-thiamine-responsive basal ganglia disease. Schänzer A; Döring B; Ondrouschek M; Goos S; Garvalov BK; Geyer J; Acker T; Neubauer B; Hahn A Brain Pathol; 2014 Apr; 24(3):270-9. PubMed ID: 24372704 [TBL] [Abstract][Full Text] [Related]
20. Reversible lactic acidosis in a newborn with thiamine transporter-2 deficiency. Pérez-Dueñas B; Serrano M; Rebollo M; Muchart J; Gargallo E; Dupuits C; Artuch R Pediatrics; 2013 May; 131(5):e1670-5. PubMed ID: 23589815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]